What does Alpha Cognition Inc. Common Stock do?
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical…
What is Alpha Cognition Inc. Common Stock's P/E and P/B ratio?
Alpha Cognition Inc. Common Stock has a P/E ratio of -6.3 and a P/B ratio of 3.42.
What is Alpha Cognition Inc. Common Stock's debt-to-equity ratio?
Alpha Cognition Inc. Common Stock has a debt-to-equity ratio of 0.00.
How much does Alpha Cognition Inc. Common Stock owe compared with what it owns?
Alpha Cognition Inc. Common Stock owes $0.18 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Alpha Cognition Inc. Common Stock's Positivity rank?
Alpha Cognition Inc. Common Stock is ranked #5,099 of 6,774 companies globally and #2,709 of 4,000 in United States on PositoAI, with a Positivity Score of 18,393.
Does Alpha Cognition Inc. Common Stock have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Alpha Cognition Inc. Common Stock.
Where can I read the latest news about Alpha Cognition Inc. Common Stock?
Recent headlines about Alpha Cognition Inc. Common Stock from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Alpha Cognition Inc. Common Stock have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Alpha Cognition Inc. Common Stock's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.